Eagle Pharmaceuticals (EGRX) director Graves acquired 9,360 shares at $4.94
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Michael Graves (director at Eagle Pharmaceuticals Inc., EGRX) reported that they acquired 9,360 shares at $4.94 on Oct 27, 2023. After these transactions the filing shows 10,360 shares held directly.
- Reporting person
- Graves Michael
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Oct 27, 2023 | Exercise or conversion of a derivative (M) | Common Stock | +9,360 | $4.94 | $46.2K | 10,360 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Oct 27, 2023 | Exercise or conversion of a derivative (M) | Stock Option (right to buy)On 9,360 Common Stock1 | -9,360 | - | - | 0 direct |
Holdings before and after
- Common Stock: 1,000 to 10,360 direct
- Stock Option (right to buy): 9,360 to 0 direct
Footnotes from the filing
- 1. Fully vested and exercisable.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Graves report in this EGRX Form 4?
Michael Graves (director at Eagle Pharmaceuticals Inc., EGRX) reported that they acquired 9,360 shares at $4.94 on Oct 27, 2023. After these transactions the filing shows 10,360 shares held directly.
How many EGRX shares does Graves hold after this filing?
The filing shows 10,360 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for EGRX
Earlier insider filings at EGRX
- Oct 4, 2023Tarriff Scott sold $300,026 worth of shares (20,245 units at $14.82), decreasing direct ownership by 3% to 567,066 units (SEC Form 4)
- May 18, 2023SEC Form 4 filed by Tarriff Scott
- May 16, 2023SEC Form 4 filed by Tarriff Scott
- Mar 10, 2023SEC Form 4 filed by Ratoff Steven B
- Mar 10, 2023SEC Form 4 filed by Graves Michael
Quantisnow market dataNASDAQ
EGRX
Eagle Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2014
Get push alerts for EGRX
Full EGRX profile on Quantisnow Follow EGRX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time